会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明申请
    • Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
    • 将生物材料无缝连接到可植入生物假体框架的方法
    • US20050021136A1
    • 2005-01-27
    • US10770978
    • 2004-02-02
    • Hua XieLisa Buckley
    • Hua XieLisa Buckley
    • A61F2/06A61F2/24
    • A61F2/2418A61F2/2475A61F2220/0075A61F2230/0026
    • A bioprosthetic valve graft comprises a valve frame and valve flaps, the latter acting to open or close a valve aperture to directionally control fluid flow through the bioprosthesis. The bioprosthetic valve graft comprises method for suturelessly attaching a biomaterial suturelessly bonded to the A method for securing a biomaterial to a valve frame includes positioning a flexible valve frame defining an open area on a first major surface of a biomaterial sheet having a peripheral edge, wherein positioning serves to approximate the valve frame and the peripheral edge of the biomaterial sheet to form an at least first bonding locus: and suturelessly bonding the biomaterial to the valve frame at the at least first bonding locus. The method avoids the disadvantages associated with conventional sutures and substantially reduces medical complications in implantations.
    • 生物假体瓣膜移植物包括阀框架和瓣瓣,后者用于打开或关闭阀孔以定向地控制通过生物假体的流体流动。 生物假体瓣膜移植物包括用于将无缝结合到A方法上的生物材料无缝连接的方法,用于将生物材料固定到瓣膜框架上的方法包括将限定开口区域的柔性瓣膜框架定位在具有周边边缘的生物材料片材的第一主表面上,其中 定位用于近似生物材料板的阀框架和周边边缘以形成至少第一粘合位置;以及在至少第一粘合位置处将生物材料无缝地结合到阀框架。 该方法避免了与常规缝线相关的缺点并且显着减少了植入物中的医疗并发症。
    • 32. 发明申请
    • MICROFLUIDIC CHIP-BASED DNA COMPUTER
    • 基于微流控芯片的DNA计算机
    • US20110177980A1
    • 2011-07-21
    • US11759048
    • 2007-06-06
    • Bingcheng LinBowel LiHua XieJianhua QinYisheng ZhuZhende Huang
    • Bingcheng LinBowel LiHua XieJianhua QinYisheng ZhuZhende Huang
    • C40B60/08
    • B82Y10/00G06N99/007
    • The present invention relates to computer science, molecular biology and microfluidics technique which provides a DNA molecular computer based on microfluidic chip. The objective is to provide a DNA molecular computer which uses the microfluidic chip as a operation platform, mainly including: using DNA molecules as operation media, using the microfluidic chip as the operation platform of a DNA molecular operator; using DNA molecules as storage media, using the microfluidic chip as the operation platform of a DNA molecular storage; using a electronic computer and a detector as the kernel of a controller; said microfluidic chip includes a DNA molecular computation region and a DNA molecular storage region. The microfluidic chip consists of digestion, ligation, PCR amplification and chip electrophoresis unit connected by microchannels in turn, and carries out the liquid control through micropumps and microvalves.
    • 本发明涉及计算机科学,分子生物学和微流体技术,其提供了基于微流控芯片的DNA分子计算机。 目的是提供一种使用微流控芯片作为操作平台的DNA分子计算机,主要包括:使用DNA分子作为操作介质,使用微流控芯片作为DNA分子操作者的操作平台; 使用DNA分子作为存储介质,使用微流控芯片作为DNA分子存储的操作平台; 使用电子计算机和检测器作为控制器的内核; 所述微流体芯片包括DNA分子计算区域和DNA分子存储区域。 微流控芯片由消化,连接,PCR扩增和芯片电泳单元依次由微通道连接,并通过微泵和微型阀进行液体控制。
    • 33. 发明申请
    • Wound dressing devices and methods
    • 伤口敷料装置及方法
    • US20100172958A1
    • 2010-07-08
    • US12387378
    • 2009-05-01
    • Lisa LucchesiHua Xie
    • Lisa LucchesiHua Xie
    • A61K31/722A61L15/26A61P17/02
    • A61L15/28C08L5/08
    • The present invention provides an absorbent wound dressing assembly that can be used to stanch, seal, or stabilize a site of tissue injury, tissue trauma, or tissue access. The wound dressing assembly is flexible so that it can be adapted and used to fit in narrow and small wound sites. Generally the wound dressing assembly comprises a flexible carrier material that is impregnated with a non-mammalian material for control of severe bleeding. The preferred non-mammalian material is poly [β-(1→4)-2-amino-2-deoxy-D-glucopyranose] more commonly referred to as chitosan.
    • 本发明提供一种吸收性伤口敷料组件,其可用于对组织损伤,组织创伤或组织进入部位进行固定,密封或稳定。 伤口敷料组件是柔性的,使得它可以适应并用于适应狭窄和小的伤口部位。 伤口敷料组件通常包括用非哺乳动物材料浸渍以控制严重出血的柔性载体材料。 优选的非哺乳动物材料是通常被称为壳聚糖的聚[和(1→4)-2-氨基-2-脱氧-D-吡喃葡萄糖]。